RSS
18 Sep 2020

Orfadin® (nitisinone) receives positive opinion from CHMP for treatment of AKU

Author: admintech | Filed under: Press Release

STOCKHOLM, Sept. 18, 2020 /PRNewswire/ — Swedish Orphan Biovitrum AB (publ) (Sobi™) today announces that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for Orfadin® (nitisinone) for the treatment of adult…

This entry was posted on Friday, September 18th, 2020 at 7:13 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»